Company / Book Value per Share
CG Oncology, Inc. Book Value per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$9.736
FY2025
5-year range
-$28.423 / $11.735
FY2023-FY2025
Trend
-17.0%
vs FY2024
Sector context
#55 of 209
Health Care
What the data says
At $9.736, CG Oncology, Inc.'s book value per share ranks #55 of 209 in the Health Care sector. Improved from -$28.423 to $9.736 over the past 2 years.
Based on SEC 10-K filings.
$9.736 in FY2025.
Improved from -$28.423 to $9.736 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#55 of 209 in Health CareTop 26% of 209This company $9.736 Sector average $189.239
▼
-94.9% below sector average
Key checks
Key Insights
- In FY2025, book value per share decreased 17.0% year-over-year.
- Ranks #55 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.736 | -17.0% |
| FY2024 | $11.735 | +141.3% |
| FY2023 | -$28.423 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026